These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 26872015)

  • 1. Hormonal Eligibility Criteria for 'Includes Females' Competition: A Practical but Problematic Solution.
    Allen DB
    Horm Res Paediatr; 2016; 85(4):278-82. PubMed ID: 26872015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethics of Regulating Competition for Women with Hyperandrogenism.
    Camporesi S
    Clin Sports Med; 2016 Apr; 35(2):293-301. PubMed ID: 26832978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impossible "Choices": The Inherent Harms of Regulating Women's Testosterone in Sport.
    Karkazis K; Carpenter M
    J Bioeth Inq; 2018 Dec; 15(4):579-587. PubMed ID: 30117064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Interconnected Histories of Endocrinology and Eligibility in Women's Sport.
    Rogol AD; Pieper LP
    Horm Res Paediatr; 2018; 90(4):213-220. PubMed ID: 30336491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The new policy on hyperandrogenism in elite female athletes is not about "sex testing".
    Sánchez FJ; Martínez-Patiño MJ; Vilain E
    J Sex Res; 2013; 50(2):112-5. PubMed ID: 23320653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. When does an advantage become unfair? Empirical and normative concerns in Semenya's case.
    Camporesi S
    J Med Ethics; 2019 Nov; 45(11):700-704. PubMed ID: 31527141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Fluidity of Gender and Implications for the Biology of Inclusion for Transgender and Intersex Athletes.
    Harper J; Lima G; Kolliari-Turner A; Malinsky FR; Wang G; Martinez-Patino MJ; Angadi SS; Papadopoulou T; Pigozzi F; Seal L; Barrett J; Pitsiladis YP
    Curr Sports Med Rep; 2018 Dec; 17(12):467-472. PubMed ID: 30531465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Out of bounds? A critique of the new policies on hyperandrogenism in elite female athletes.
    Karkazis K; Jordan-Young R; Davis G; Camporesi S
    Am J Bioeth; 2012; 12(7):3-16. PubMed ID: 22694023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The International Olympic Committee framework on fairness, inclusion and nondiscrimination on the basis of gender identity and sex variations does not protect fairness for female athletes.
    Lundberg TR; Tucker R; McGawley K; Williams AG; Millet GP; Sandbakk Ø; Howatson G; Brown GA; Carlson LA; Chantler S; Chen MA; Heffernan SM; Heron N; Kirk C; Murphy MH; Pollock N; Pringle J; Richardson A; Santos-Concejero J; Stebbings GK; Christiansen AV; Phillips SM; Devine C; Jones C; Pike J; Hilton EN
    Scand J Med Sci Sports; 2024 Mar; 34(3):e14581. PubMed ID: 38511417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperandrogenic athletes: performance differences in elite-standard 200m and 800m finals.
    Ospina Betancurt J; Zakynthinaki MS; Martinez-Patiño MJ; Cordente Martinez C
    J Sports Sci; 2018 Nov; 36(21):2464-2471. PubMed ID: 29659337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperandrogenism and intersex controversies in women's olympics.
    Xavier NA; McGill JB
    J Clin Endocrinol Metab; 2012 Nov; 97(11):3902-7. PubMed ID: 22990091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The End of Compulsory Gender Verification: Is It Progress for Inclusion of Women in Sports?
    Ospina-Betancurt J; Vilain E; Martinez-Patiño MJ
    Arch Sex Behav; 2021 Oct; 50(7):2799-2807. PubMed ID: 34494166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administering drugs to an individual in a non-pathological situation: The Caster Semenya case.
    Jagadeesh N
    Indian J Med Ethics; 2020; V(2):139-143. PubMed ID: 32393456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender verification in competitive sports.
    Simpson JL; Ljungqvist A; de la Chapelle A; Ferguson-Smith MA; Genel M; Carlson AS; Ehrhardt AA; Ferris E
    Sports Med; 1993 Nov; 16(5):305-15. PubMed ID: 8272686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large divergence in testosterone concentrations between men and women: Frame of reference for elite athletes in sex-specific competition in sports, a narrative review.
    Clark RV; Wald JA; Swerdloff RS; Wang C; Wu FCW; Bowers LD; Matsumoto AM
    Clin Endocrinol (Oxf); 2019 Jan; 90(1):15-22. PubMed ID: 30136295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caster Semenya, athlete classification, and fair equality of opportunity in sport.
    Loland S
    J Med Ethics; 2020 Sep; 46(9):584-590. PubMed ID: 32690761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination and regulation of body composition in elite athletes.
    Sonksen P
    Br J Sports Med; 2018 Feb; 52(4):219-229. PubMed ID: 27879256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hurdling over sex? Sport, science, and equity.
    Ha NQ; Dworkin SL; Martínez-Patiño MJ; Rogol AD; Rosario V; Sánchez FJ; Wrynn A; Vilain E
    Arch Sex Behav; 2014 Aug; 43(6):1035-42. PubMed ID: 25085349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global injustice in sport: The Caster Semenya ordeal - prejudice, discrimination and racial bias.
    Mahomed S; Dhai A
    S Afr Med J; 2019 Jul; 109(8):548-551. PubMed ID: 31456545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transgender Women in the Female Category of Sport: Perspectives on Testosterone Suppression and Performance Advantage.
    Hilton EN; Lundberg TR
    Sports Med; 2021 Feb; 51(2):199-214. PubMed ID: 33289906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.